MedTrace Logo

Understanding Acute Dietary Changes After GLP-1 Agonist Treatment: The GLaD Feasibility Study

NCT07001553 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2026-03-02

No results posted yet for this study

Summary

An observational study of those who have been prescribed a GLP-1 agonist therapy (yet to commence), for either weight or diabetes management, and are willing to complete dietary records and questionnaires of behaviour and psychosocial health.

Conditions

  • Obesity
  • Type 2 Diabetes Mellitus (T2DM)

Sponsors & Collaborators

  • St Vincent's Hospital Melbourne

    collaborator OTHER

  • The University of Queensland

    collaborator OTHER

  • Australian Catholic University

    lead OTHER

Principal Investigators

  • Evelyn B Parr, PhD · Australian Catholic University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-28
Primary Completion
2026-01-07
Completion
2026-01-07

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07001553 on ClinicalTrials.gov